ORY-1001 treatment did not induce ZFP36L1 in the 3 resistant AML cell lines (K562, HL60, U937) (Fig. 7g and Supplementary Fig. 17d). The gene discussed is ZFP36L1; the disease is acute myeloid leukemia.